News
Artificial intelligence, technology, science, health and education — reported daily, with the original source attached to every item.
Showing articles about clinical trial
8 stories
Urine RNA Test Detects 95% of Localized Bladder Cancers in 683-Sample Stanford Study
A Stanford Medicine study in Nature Medicine (October 2, 2026) found a urine RNA test detected 95% of localized bladder cancers and 90% of …
REMODEL Trial: Semaglutide Misses Its Primary Kidney MRI Goals, but Biopsies Show a Fibrosis Signal
Nature Medicine published the REMODEL trial on October 1, 2026: semaglutide missed its coprimary MRI endpoints in 106 people with type 2 di…
Oncolytic Virus Added to Chemotherapy Shows a Survival Signal in Pancreatic Cancer, With Mixed Results on Significance
A phase 2b trial published in Nature Medicine on September 30, 2026 found VCN-01, an engineered oncolytic virus, added to chemotherapy leng…
Phase 3 Trial Finds Dual-Agonist Drug Survodutide Cuts Weight 13.1% in Adults With Type 2 Diabetes
A phase 3 trial published in NEJM on October 1, 2026 found that weekly survodutide, a dual glucagon/GLP-1 receptor agonist, produced up to …
Single-Infusion In Vivo CAR T-Cell Therapy Eases Four Neurologic Autoimmune Diseases in Small NEJM Trial
A 16-patient trial published in NEJM on September 3, 2026 tested a single-infusion lentiviral vector that generates CD19 CAR T cells inside…
Gene Therapy Cuts Bleeding Episodes in Adolescents With Hemophilia B, Small Phase 1 Trial Finds
A phase 1 trial in Nature Medicine found that a single AAV gene therapy infusion cut bleeding episodes in 11 adolescents with hemophilia B,…
Phase 1 Trial Finds a Cancer-Style T-Cell Engager Can Push Refractory Lupus Into Remission
A phase 1 trial of A-319, a CD3×CD19 bispecific antibody adapted from cancer therapy, pushed most of 12 treatment-resistant lupus patients …
Randomized Trial Finds Teclistamab Outperforms Standard Early Treatment in High-Risk Smoldering Myeloma
A phase 2 trial in Nature Medicine found that early teclistamab treatment produced deep, durable remissions in high-risk smoldering myeloma…